Síndrome neuroléptica maligna de paciente em uso de olanzapina

Medeiros, Fabrício Lins de; Andrade, Arthur Guerra de; Hiroce, Vivian Yuri; Alves, Tânia Corrêa de Toledo Ferraz.
J. bras. psiquiatr ; 57(2): 145-147, 2008.
Artículo en Portugués | LILACS | ID: lil-492118

Documentos relacionados

  1. Therapeutic monitoring of antipsychotics with a focus on lurasidone and its dosing.
  2. Therapeutic monitoring of antipsychotics with a focus on lurasidone and its dosing.
  3. Delusional infestation: a retrospective cohort study of 49 patients over a 6-year period.
  4. Evidence for Therapeutic Drug Monitoring of Atypical Antipsychotics.
  5. Neuropharmacokinetic visualization of regional and subregional unbound antipsychotic drug transport across the blood-brain barrier.
  6. Epigenetics for Drug Discovery: Dissecting the Effect of High Antipsychotic Dosage and D2 Blockage on Peripheral DNA Methylation.
  7. Community, Social, and Facility Factors and Long-stay Antipsychotic Use.
  8. Dopaminergic dysfunction and excitatory/inhibitory imbalance in treatment-resistant schizophrenia and novel neuromodulatory treatment.
  9. Using Antipsychotics for Self-Defense Purposes by Care Staff in Residential Aged Care Facilities: An Ethical Analysis.
  10. Research based treatment through neuroleptics (antipsychotics) in Pakistan: Can it be trusted?